Proteins of purified Epstein-Barr virus
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Mature Epstein-Barr virus (EBV) was purified from the culture medium of infected lymphocytes made functionally conditional for Zta activation of lytic replication by an in-frame fusion with a mutant estrogen receptor. Proteins in purified virus preparations were separated by gradient gel electrophoresis and trypsin-digested; peptides were then analyzed by tandem hydrophobic chromatography, tandem MS sequencing, and MS scans. Potential peptides were matched with EBV and human gene ORFs. Mature EBV was mostly composed of homologues of proteins previously found in a herpes virion. However, EBV homologues to herpes simplex virus capsid-associated or tegument components UL7 (BBRF2), UL14 (BGLF3), and EBV BFRF1 were not significantly detected. Instead, probable tegument components included the EBV and γ-herpesvirus-encoded BLRF2, BRRF2, BDLF2 and BKRF4 proteins. Actin was also a major tegument protein, and cofilin, tubulin, heat shock protein 90, and heat shock protein 70 were substantial components. EBV envelope glycoprotein gp350 was highly abundant, followed by glycoprotein gH, intact and furin-cleaved gB, gM, gp42, gL, gp78, gp150, and gN. BILF1 (gp64) and proteins associated with latent EBV infection were not detected in virions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For compositional analysis, most studies have focused on viruses with high proteomic complexity, including those in the families Herpesviridae (4–9) and Poxviridae (10–12).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [4]
Citations
Cites
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,467
Three-Dimensional Structure of Herpes Simplex Virus from Cryo-Electron Tomography
Grünewald, K., Desai, P., Winkler, D. C., Heymann, J. B., Belnap, D. M., Baumeister, W., & Steven, A. C. (2003) · Science · doi:10.1126/science.1090284 · Cited by 586
Evolution of the herpesviruses
Davison, A. J. (2002) · Veterinary Microbiology · doi:10.1016/s0378-1135(01)00492-8 · Cited by 336
Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
Li, Q., Spriggs, M. K., Kovats, S., Turk, S. M., Comeau, M. R., Nepom, B., & Hutt-Fletcher, L. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4657-4662.1997 · Cited by 319
The UL6 Gene Product Forms the Portal for Entry of DNA into the Herpes Simplex Virus Capsid
Newcomb, W. W., Juhas, R. M., Thomsen, D. R., Homa, F. L., Burch, A. D., Weller, S. K., & Brown, J. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10923-10932.2001 · Cited by 309
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
Tugizov, S. M., Berline, J. W., & Palefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm830 · Cited by 286
Proteins associated with purified human cytomegalovirus particles
Baldick, C. J., & Shenk, T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6097-6105.1996 · Cited by 176
Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M., Payne, G. H., & Saifuddin, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4376 · Cited by 169
Grogan, E. A., Jenson, H. B., Countryman, J. K., Heston, L., Gradoville, L., & Miller, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1332 · Cited by 137
Research works printed but not linked: 2
- Hutt-Fletcher, L. M. & Lake, C. M. (2001) Curr. Top. Microbiol. Immunol. 258, 51-64.11443867
- Iwase, H. & Hotta, K. (1993) Methods Mol. Biol. 14, 151-159.8348231
Cited by
Items 201–300 of 450
DNA-tumor virus entry—From plasma membrane to the nucleus
Püntener, D., & Greber, U. F. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.03.014 · Cited by 27
“UL36 (VP1/2) together with UL37 and UL25 is one of the innermost capsid associated tegument proteins that remain associated with the incoming capsids until docking at the NPC. UL36 deletion mutants failed to spread the infection to uninfected nuclei in experimentally induced syncitia indicating that UL36 was required…”
BackgroundInfluentialBenach, J., Wang, L., Chen, Y., Ho, C. K., Lee, S., Seetharaman, J., Xiao, R., Acton, T., Montelione, G. T., Deng, H., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705637200 · Cited by 28
Nanbo, A., Kachi, K., Yoshiyama, H., & Ohba, Y. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000605 · Cited by 27
“…is not required for cell-to-cell fusion (Haan et al., 2001; McShane & Longnecker, 2004) and apparently very few BMRF2 molecules exist on the virion (Johannsen et al., 2004), suggesting that undefined additional receptors in epithelial cells may function in the transmission of EBV mediated by cell…”
BackgroundIdentification and characterization of the pseudorabies virus UL43 protein
Klupp, B. G., Altenschmidt, J., Granzow, H., Fuchs, W., & Mettenleiter, T. C. (2005) · Virology · doi:10.1016/j.virol.2005.01.032 · Cited by 25
“The UL43 homologous protein in Epstein–Barr–Virus (EBV), the product of the BMRF2 gene, is a 53- to 55-kDa virion polypeptide which is associated with intracellular membranes (Johannsen et al., 2004; Modrow et al., 1992; Tugizov et al., 2003).”
BackgroundMay, J. S., de Lima, B. D., Colaco, S., & Stevenson, P. G. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00316.x · Cited by 25
“Similarly, there is relatively little BMRF2 in EBV virions (23), which has led to the suggestion that it too may be involved mainly in cell/ cell viral spread (23).”
BackgroundProteomic Characterization of Murid Herpesvirus 4 Extracellular Virions
Vidick, S., Leroy, B., Palmeira, L., Machiels, B., Mast, J., François, S., Wattiez, R., Vanderplasschen, A., & Gillet, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083842 · Cited by 24
Braconi, C. T., Ardisson-Araújo, D. M. P., Leme, A. F. P., Oliveira, J., Pauletti, B. A., Garcia-Maruniak, A., Ribeiro, B. M., Maruniak, J. E., & Zanotto, P. M. D. A. (2014) · Journal of General Virology · doi:10.1099/vir.0.061127-0 · Cited by 25
Atypical immune response to Epstein-Barr virus in major depressive disorder
Jones‐Brando, L. V., Dickerson, F., Ford, G. M., Stallings, C. R., Origoni, A. E., Katsafanas, E., Sweeney, K., Squire, A., Khushalani, S., & Yolken, R. H. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.150 · Cited by 24
“Although we do not know for certain the specific gene identity for VCA p42, we tentatively identify it as tegument protein BKRF4 (Johannsen et al., 2004).”
BackgroundInfluentialViral proteomics: The emerging cutting-edge of virus research
Zhou, S. T., Liu, R., Zhao, X., Huang, C., & Wei, Y. (2011) · Science China Life Sciences · doi:10.1007/s11427-011-4177-7 · Cited by 28
“SILAC involves a straightforward metabolic labeling method, where the cells are grown in medium containing amino acids with stable nonabundant isotopes (e.g., 15 N, 13 C and 2 D) and compared with the cells grown in medium containing stable abundant isotopes ( 14 N, 12 C and 1 H).”
Proteomic analysis of purified Newcastle disease virus particles
Ren, X., Xue, C., Kong, Q., Zhang, C., Bi, Y., & Cao, Y. (2012) · Proteome Science · doi:10.1186/1477-5956-10-32 · Cited by 27
“3 453 12 HIV[31,32], SARS [33,34], IV[35], VV [25,26], EBV[19], HCMV[17], KSHV[20,21], VSV[36], IBV[37], PRRSV[38]”
BackgroundInfluentialMolecular characterization of duck enteritis virus UL41 protein
He, T., Wang, M., Cao, X., Cheng, A., Wu, Y., Yang, Q., Liu, M., Zhu, D., Jia, R., Chen, S., et al. (2018) · Virology Journal · doi:10.1186/s12985-018-0928-4 · Cited by 23
SoRelle, E. D., Reinoso-Vizcaíno, N. M., Dai, J., Barry, A. P., Chan, C. C. W., & Luftig, M. A. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112958 · Cited by 24
“Single-cell chromatin accessibility (scATAC-seq) libraries were prepared from B cells prior to (day 0) and following de novo infection with B95-8 EBV 31 at three time points (days 2, 5, and 8).”
Self-citationProteomic Characterization of Bovine Herpesvirus 4 Extracellular Virions
Lété, C., Palmeira, L., Leroy, B., Mast, J., Machiels, B., Wattiez, R., Vanderplasschen, A. F. C., & Gillet, L. (2012) · Journal of Virology · doi:10.1128/jvi.00456-12 · Cited by 27
“According to that hypothesis, pORF23 was not identified in KSHV, MuHV-4, and AlHV-1, and only very low levels were observed in EBV virions (25).”
BackgroundMethodInfluentialInitial Characterization of the Epstein–Barr Virus BSRF1 Gene Product
Yanagi, Y., Masud, H. M. A. A., Watanabe, T., Sato, Y., Goshima, F., Kimura, H., & Murata, T. (2019) · Viruses · doi:10.3390/v11030285 · Cited by 23
“Two other tegument components, tubulin and BRRF2 [9,16], were tightly attached to the nucleocapsids and were not dissociated by treatment with a detergent and salt, although tubulin may have been slightly dissociated (lane 3).”
BackgroundEl-Guindy, A. S., Heston, L., Delecluse, H., & Miller, G. (2007) · Journal of Virology · doi:10.1128/jvi.02445-06 · Cited by 23
De Novo Polycomb Recruitment: Lessons from Latent Herpesviruses
Dochnal, S. A., Francois, A. K., & Cliffe, A. R. (2021) · Viruses · doi:10.3390/v13081470 · Cited by 19
“When Herpesvirus genomes first enter the nucleus, they are not associated with cellular histone proteins and are therefore epigenetically naïve [67-72].”
BackgroundPathogenic microbes manipulate cofilin activity to subvert actin cytoskeleton
Zheng, K., Kitazato, K., Wang, Y., & He, Z. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1010139 · Cited by 24
“As expected, cofilin has been incorporated into numerous viral particles, such as HIV (Ott et al., 1996), Influenza A virus (IAV) (Shaw et al., 2008), Hepatitis B virus (HBV) (Johannsen et al., 2004), Porcine reproductive and respiratory syndrome virus (PRRSV) (Zhang et al., 2010), Hepatitis C virus (HCV) (Kang et al.…”
BackgroundMethodStructure of the C-Terminal Domain of the Multifunctional ICP27 Protein from Herpes Simplex Virus 1
Patel, V., Dahlroth, S., Rajakannan, V., Ho, H. T., Cornvik, T. C., & Nordlund, P. (2015) · Journal of Virology · doi:10.1128/jvi.00441-15 · Cited by 25
Durán, A. H., Greco, T. M., Vollmer, B., Cristea, I. M., Grünewald, K., & Topf, M. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000316 · Cited by 27
Novel neutralizing human monoclonal antibodies against tetanus neurotoxin
Minamitani, T., Kiyose, K., Otsubo, R., Ito, T., Akiba, H., Furuta, R. A., Tsuyoshi Inoue, A., Tsumoto, K., Satake, M., & Yasui, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-91597-2 · Cited by 22
de Jong, J., Theilmann, D. A., Arif, B. M., & Krell, P. J. (2011) · Journal of Virology · doi:10.1128/jvi.00833-11 · Cited by 24
“This is supported by the fact that actin was identified through mass spectrophotometry analysis of budded virions from Epstein-Barr virus (16), human cytomegalovirus (37), HIV (7), and, more recently, AcMNPV (42).”
BackgroundIdentification of Epstein-Barr Virus Replication Proteins in Burkitt’s Lymphoma Cells
Traylen, C. M., Ramasubramanyan, S., Zuo, J., Rowe, M., Al-Mohammad, R., Heesom, K. J., Sweet, S. M. M., Matthews, D. A., & Sinclair, A. J. (2015) · Pathogens · doi:10.3390/pathogens4040739 · Cited by 22
“In addition to the analysis of viral proteins within cells, proteins present in purified EBV virions have also been detected using proteomics [32].”
BackgroundChesnokova, L. S., Valencia, S. M., & Hutt‐Fletcher, L. M. (2016) · Virology · doi:10.1016/j.virol.2016.04.002 · Cited by 24
“Glycoprotein gp350 is not only the most abundant virus glycoprotein (Johannsen et al., 2004), it is also modeled as a long extended structure (Moore et al.”
BackgroundDooley, M. M., de Gannes, S. L., Fu, K. A., & Lindsey, J. W. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.016 · Cited by 22
“component of the virus capsid and BRRF2, although of unknown function, is also present in the mature virus (Johannsen et al., 2004).”
BackgroundGale, T. V., Horton, T. M., Hoffmann, A. R., Branco, L. M., & Garry, R. F. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00204 · Cited by 27
Volkening, J. D., Spatz, S. J., Ponnuraj, N., Akbar, H., Arrington, J. V., Vega‐Rodriguez, W., & Jarosinski, K. W. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011204 · Cited by 20
“In other herpesvirus proteomics studies, this protein has also been difficult to detect [20,23,27,28,68].”
BackgroundSimbiri, K. O., Smith, N. A., Otieno, R., Wohlford, E. M., Daud, I. I., Odada, S. P., Middleton, F. A., & Rochford, R. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125420 · Cited by 21
“BRRF2 plays a role in translation [29], viral assembly [30], DNA replication [31], nuclear egress of capsid [32], and has been reported to be involved in multiple other activities such as regulation of transcription [33].”
BackgroundLoret, S., & Lippé, R. (2011) · Journal of General Virology · doi:10.1099/vir.0.039776-0 · Cited by 28
“…has been detected in Kaposi’s sarcoma-associated herpesvirus, Epstein–Barr virus and alcelaphine herpesvirus-1 virions (Bechtel et al., 2005; Dry et al., 2008; Johannsen et al., 2004; Zhu et al., 2005), although it was undetected in the aforementioned PRV proteomics study (Kramer et al., 2011).”
BackgroundCharacterization of the EBV-Induced Persistent DNA Damage Response
Hafez, A. Y., & Luftig, M. A. (2017) · Viruses · doi:10.3390/v9120366 · Cited by 21
“EBV B95-8 virus was produced from the B95-8 Z-HT cell line, as previously described [36].”
MethodSelf-citationIdentification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III
Messinger, J. E., Dai, J., Stanland, L. J., Price, A. M., & Luftig, M. A. (2019) · mBio · doi:10.1128/mbio.01006-19 · Cited by 19
“The B95-8 strain of Epstein-Barr virus was generated from the B95-8 Z-HT cell line as previously described (39).”
MethodSelf-citationCellular Proteins Associated with the Interior and Exterior of Vesicular Stomatitis Virus Virions
Moerdyk-Schauwecker, M. J., Hwang, S., & Grdzelishvili, V. Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104688 · Cited by 23
“To comprehensively look at host protein incorporation, a number of purified viruses have been analyzed by mass spectrometry including poxviruses [22,23,24], herpesviruses [25,26,27,28,29,30,31,32], orthomyxoviruses [33], coronaviruses [34,35], retroviruses [36,37,38,39], paramyxoviruses [40,41], baculoviruses [42], hy…”
Gu, A.-D., Xie, Y.-B., Mo, H., Jia, W.-H., Li, M.-Y., Li, M., Chen, L.-Z., Feng, Q.-S., Liu, Q., Qian, C.-N., et al. (2008) · Journal of General Virology · doi:10.1099/vir.0.83686-0 · Cited by 21
“So far, 12 EBV glycoproteins have been characterized (Johannsen et al., 2004).”
BackgroundThe Epstein-Barr Virus Major Tegument Protein BNRF1 Is a Common Target of Cytotoxic CD4+T Cells
Adhikary, D., Damaschke, J., Mautner, J., & Behrends, U. (2020) · Journal of Virology · doi:10.1128/jvi.00284-20 · Cited by 20
“Viral particles contain over 30 different proteins of the virus (17).”
BackgroundWang, L., Guo, H., Reyes, N., Lee, S., Bortz, E., Guo, F., Sun, R., Tong, L., & Deng, H. (2011) · Journal of Virology · doi:10.1128/jvi.05497-11 · Cited by 20
Structural Proteomics of Herpesviruses
Leroy, B., Gillet, L., Vanderplasschen, A. F. C., & Wattiez, R. (2016) · Viruses · doi:10.3390/v8020050 · Cited by 23
“Proteolysis of the particle preparation has also been frequently used as a means to demonstrate incorporation of cellular proteins into the virion [16,26,28,29].”
BackgroundMethodWang, H., Bu, L., Wang, C., Zhang, Y., Zhou, H., Zhang, X., Guo, W., Long, C., Guo, D., & Sun, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0779-3 · Cited by 23
Asai, R., Kato, A., & Kawaguchi, Y. (2009) · Journal of General Virology · doi:10.1099/vir.0.010462-0 · Cited by 20
“Epstein–Barr virus (EBV) BGLF4 is a serine/threonine protein kinase and is packaged in the virion tegument, the structural component between the virion nucleocapsid and envelope (Asai et al., 2006; Johannsen et al., 2004; Wang et al., 2005).”
BackgroundDorothea, M., Xie, J., Yiu, S. P. T., & Chiang, A. (2023) · Cancers · doi:10.3390/cancers15072120 · Cited by 21
Mounce, B. C., Mboko, W. P., Bigley, T. M., Terhune, S. S., & Tarakanova, V. L. (2013) · Journal of Virology · doi:10.1128/jvi.02713-12 · Cited by 20
“However, the role of gammaherpesvirus kinase in the context of de novo lytic infection has not been fully appreciated, in spite of the fact that gammaherpesvirus kinases are virion components (42).”
BackgroundThe Promise of Proteomics in the Study of Oncogenic Viruses
McBride, A. A. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o116.065201 · Cited by 20
“The components of the large, enveloped EBV and KHSV virions have been analyzed by LC-MS/MS, revealing 24-34 viral proteins in the viral capsid, tegument and envelopes, as well as several host proteins (22, 23).”
Johnson, S. N., Wheeler, J. X., Thorpe, R., Collins, M. K., Takeuchi, Y., & Zhao, Y. (2018) · Biologicals · doi:10.1016/j.biologicals.2017.12.005 · Cited by 20
Conto, F. D., Lonardo, E. D., Arcangeletti, C., Chezzi, C., Medici, M. C., & Calderaro, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041207 · Cited by 23
Gill, M. B., Kutok, J. L., & Fingeroth, J. D. (2007) · Journal of Virology · doi:10.1128/jvi.00147-07 · Cited by 24
“However, if abortive replication occurs, or if EBV TK is briefly delivered upon initial infection (38), or if the enzyme is selectively induced during latency by transient ribonucleotide reductase inhibition (51) or other forms of genotoxic stress that cause replication stalling (5), then transient centrosome dysregul…”
BackgroundSato, Y., Yaguchi, M., Okuno, Y., Ishimaru, H., Sagou, K., Ozaki, S., Suzuki, T., Inagaki, T., Umeda, M., Watanabe, T., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00902-7 · Cited by 19
Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
Wu, Q., Zhong, L., Wei, D., Zhang, W., Hong, J., Kang, Y., Chen, K., Huang, Y., Zheng, Q., Xu, M., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2245920 · Cited by 18
“Both gp350 and gp42 are unique to EBV and are involved in B cell infection [10]. gp350 is the most abundant envelope glycoprotein on the virion surface and is involved in attachment to the target cell surface through binding to complement receptor type 2 (CR2/ CD21) or to CR1 (CD35) [11,12].”
BackgroundThe autophagy machinery interacts with EBV capsids during viral envelope release
Pena-Francesch, M., Vanoaica, L. D., Zhu, G., Stumpe, M., Sankar, D. S., Nowag, H., Valencia-Camargo, A. D., Hammerschmidt, W., Dengjel, J., Ligeon, L., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211281120 · Cited by 19
Han, Z., Verma, D., Hilscher, C., Dittmer, D. P., & Swaminathan, S. (2009) · Journal of Virology · doi:10.1128/jvi.01483-09 · Cited by 18
New insights into viral structure and virus–cell interactions through proteomics
Bernhard, O. K., Diefenbach, R. J., & Cunningham, A. L. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.4.577 · Cited by 18
Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity
Masud, H. M. A. A., Yanagi, Y., Watanabe, T., Sato, Y., Kimura, H., & Murata, T. (2019) · Microorganisms · doi:10.3390/microorganisms7120705 · Cited by 18
“Because its homologs in other herpesviruses are tegument proteins, EBV BBRF2 is also thought to be a tegument component, although the protein has not been detected in virus particles, possibly due to its low abundance [6].”
BackgroundEpstein–Barr Virus BALF0 and BALF1 Modulate Autophagy
Shao, Z., Borde, C., Quignon, F., Escargueil, A. E., & Maréchal, V. (2019) · Viruses · doi:10.3390/v11121099 · Cited by 20
“Although initial work by Johannsen and colleagues did not identify BALF0 and BALF1 in purified EBV virions [67], another study led to co-purification of BALF0 and BALF1 with BSRF1 [68], an EBV tegument protein that is homologous to HSV-1 unique long 51 (UL51) and HCMV UL71, which is involved in virion egress.”
ResultGammaherpesviruses entry and early events during infection
Chandran, B., & Hutt‐Fletcher, L. M. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.024 · Cited by 19
EBV Reactivation from Latency Is a Degrading Experience for the Host
Casco, A., & Johannsen, E. (2023) · Viruses · doi:10.3390/v15030726 · Cited by 19
Self-citationChromatin control of human cytomegalovirus infection
Matthews, S. M., Groves, I. J., & O’Connor, C. M. (2023) · mBio · doi:10.1128/mbio.00326-23 · Cited by 26
Prospects of a novel vaccination strategy for human gamma-herpesviruses
Wu, T.-T., Blackman, M., & Sun, R. (2010) · Immunologic research · doi:10.1007/s12026-010-8172-z · Cited by 20
“There are at least eight envelope glycoproteins for human gamma-herpesviruses [45, 46].”
Purification of infectious human herpesvirus 6A virions and association of host cell proteins
Hammarstedt, M., Ahlqvist, J., Jacobson, S., Garoff, H., & Fogdell‐Hahn, A. (2007) · Virology Journal · doi:10.1186/1743-422x-4-101 · Cited by 17
“It should be noted, that HCMV [26], Epstein-Barr virus (EBV) [27] and Human herpesvirus 8 (HHV-8) [28] can be purified to levels where serum bands are not detected by the 100 times less sensitive Coomassie Brilliant blue staining [25].”
BackgroundChadha, P., Sarfo, A., Zhang, D., Abraham, T., Carmichael, J. C., Han, J., & Wills, J. W. (2016) · Journal of Virology · doi:10.1128/jvi.01995-16 · Cited by 19
Hung, C., Chiu, Y., Wang, W., Chen, L.-W., Chang, P., Huang, T., Lin, Y., Tsai, W.-J., & Yang, C.-C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03021 · Cited by 17
Althurwi, H. N., Alharthy, K. M., Albaqami, F. F., Altharawi, A., Javed, M. R., Muhseen, Z. T., & Qamar, M. T. U. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013054 · Cited by 16
Hahn, A. S., Großkopf, A. K., Jungnickl, D., Scholz, B., & Ensser, A. (2016) · Journal of Virology · doi:10.1128/jvi.01181-16 · Cited by 16
“The known viral homologs of this protein are part of the virion of HVS (13), KSHV (12), and Epstein-Barr virus (EBV) (24), and we clearly detected ORF75 in the lysate of pelleted RRV-containing cell supernatant (Fig.”
BackgroundSugimoto, A., Yamashita, Y., Kanda, T., Murata, T., & Tsurumi, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222519 · Cited by 16
Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer
Aguayo, F., Boccardo, E., Corvalán, A. H., Calaf, G. M., & Blanco, R. (2021) · Infectious Agents and Cancer · doi:10.1186/s13027-021-00391-2 · Cited by 23
“The envelope is composed of 12 glycoproteins although the fusion machinery is formed by the glycoprotein B (gB), the heterodimeric complex gH/gL, and non-conserved receptor-binding proteins [14].”
BackgroundMasa, S.-R., Lando, R., & Sarid, R. (2007) · Virology · doi:10.1016/j.virol.2007.08.023 · Cited by 16
“Unlike UL14, ORF35 has not been detected in KSHV nor in mHV-68 or in EBV virion preparations that were analyzed by mass spectrometric analysis (Bechtel et al., 2005; Bortz et al., 2003; Johannsen et al., 2004; Zhu et al., 2005).”
BackgroundVerma, D., Church, T. M., & Swaminathan, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000625117 · Cited by 16
“(4HT) receptor that allows robust induction of EBV replication upon addition of 4HT to the growth medium (63), and the 3BLCL-ZHT cell line was generated similarly (64).”
MethodSucharita, S., Krishnagopal, A., & den Hurk, S. V. D. L. (2023) · Viruses · doi:10.3390/v15102058 · Cited by 19
Burnie, J., Fernandes, C., Chaphekar, D., Wei, D., Ahmed, S., Persaud, A. T., Khader, N., Cicala, C., Arthos, J. A., Tang, V. A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-50365-0 · Cited by 15
“The technique has been used to provide comprehensive lists of cellular proteins found associated with virus preparations 13–17 .”
Update of Natural Products and Their Derivatives Targeting Epstein–Barr Infection
Pennisi, R., Trischitta, P., Costa, M. D. A., Venuti, A., Tamburello, M. P., & Sciortino, M. T. (2024) · Viruses · doi:10.3390/v16010124 · Cited by 15
“BBRF2 is an EBV tegument protein with putative homologs in all three herpesvirus subfamilies [36].”
BackgroundLongnecker, R., Hutt‐Fletcher, L. M., & Jardetzky, T. S. (2008) · Springer eBooks · doi:10.1007/978-0-387-68945-6_15 · Cited by 15
The Epstein–Barr virus BRRF2 gene product is involved in viral progeny production
Watanabe, T., Tsuruoka, M., Narita, Y., Katsuya, R., Goshima, F., Kimura, H., & Murata, T. (2015) · Virology · doi:10.1016/j.virol.2015.05.010 · Cited by 15
Orlova, N. V., Fogg, M. H., Carville, A., & Wang, F. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05126-11 · Cited by 15
“BVRF2 is a protease that associates with and is necessary for capsid formation, but only minute quantities remain in mature virions (14).”
BackgroundMass spectrometry-based investigation of measles and mumps virus proteome
Sviben, D., Forčić, D., Halassy, B., Allmaier, G. M., Marchetti‐Deschmann, M., & Brgles, M. (2018) · Virology Journal · doi:10.1186/s12985-018-1073-9 · Cited by 16
Walston, J. J., Hayman, I. R., Gore, M. L., Ferguson, M., Temple, R. M., Liao, J., Alam, S., Meyers, C., Tugizov, S. M., Hutt‐Fletcher, L. M., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01528-22 · Cited by 14
“The EBV BDLF2 protein is a glycoprotein present on the surface of the virion (17, 18).”
BackgroundEpstein–Barr virus lytic replication and cancer
Li, H., Lee, C.-Y., & Delecluse, H. (2024) · Current Opinion in Virology · doi:10.1016/j.coviro.2024.101438 · Cited by 14
Hijacking of Host Calreticulin Is Required for the White Spot Syndrome Virus Replication Cycle
Watthanasurorot, A., Guo, E., Tharntada, S., Lo, C., Söderhäll, K., & Söderhäll, I. (2014) · Journal of Virology · doi:10.1128/jvi.01014-14 · Cited by 14
“Several proteomic studies of human 430 pathogenic viruses have shown the presence of many host proteins in their virions (50-52).”
BackgroundRetractedMolecular characterization of the duck enteritis virus US10 protein
Zhang, D., Lai, M., Cheng, A., Wang, M., Wu, Y., Yang, Q., Liu, M., Zhu, D., Jia, R., Chen, S., et al. (2017) · Virology Journal · doi:10.1186/s12985-017-0841-2 · Cited by 14
Butnaru, M., & Gaglia, M. M. (2019) · Viruses · doi:10.3390/v11080711 · Cited by 14
Yao, Y., Xu, M., Liang, L., Zhang, H., Xu, R., Feng, Q., Feng, L., Luo, B., & Zeng, Y. (2017) · Tumor Biology · doi:10.1177/1010428317714195 · Cited by 14
The BOLF1 gene is necessary for effective Epstein–Barr viral infectivity
Masud, H. M. A. A., Watanabe, T., Sato, Y., Goshima, F., Kimura, H., & Murata, T. (2019) · Virology · doi:10.1016/j.virol.2019.02.015 · Cited by 14
Negative Autoregulation of Epstein-Barr Virus (EBV) Replicative Gene Expression by EBV SM Protein
Verma, D., Ling, C., Johannsen, E., Tirumuru, N., & Swaminathan, S. (2009) · Journal of Virology · doi:10.1128/jvi.00382-09 · Cited by 14
“inducer of EBV replication as described previously (33).”
MethodSelf-citationLam, W. K., Ma, B. B. Y., King, A. D., Malki, Y., Chan, K. C. A., & Chan, A. T. �. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01079-x · Cited by 13
“By contrast, the EBV detected in non-NPC samples seems to be a product of viral replication, characterized by virion-associated DNA without a nucleosomal structure 92 .”
Xia, W., Liu, L., Shi, N., Zhang, C., Tang, A., & He, G. (2023) · Virology Journal · doi:10.1186/s12985-023-02147-3 · Cited by 13
Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation
Sagou, K., Sato, Y., Okuno, Y., Watanabe, T., Inagaki, T., Motooka, Y., Toyokuni, S., Murata, T., Kiyoi, H., & Kimura, H. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011954 · Cited by 13
Epstein-Barr virus induces host shutoff extensively via BGLF5-independent mechanisms
Casco, A., Ohashi, M., & Johannsen, E. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114743 · Cited by 16
Self-citationAtyeo, N., & Papp, B. (2022) · Viruses · doi:10.3390/v14092010 · Cited by 12
“Instead, BKRF4 demonstrates early to late gene expression kinetics during lytic reactivation, with variable sensitivity to treatment with an inhibitor of viral DNA replication, phosphonoacetic acid [100,104].”
BackgroundHow Epstein-Barr Virus Induces the Reorganization of Cellular Chromatin
Rosemarie, Q., Kirschstein, E., & Sugden, B. (2023) · mBio · doi:10.1128/mbio.02686-22 · Cited by 15
Anderson, M. S., Loftus, M. S., & Kedes, D. H. (2014) · Journal of Virology · doi:10.1128/jvi.01502-14 · Cited by 15
“Homologs are present within other gammaherpesvirus virions and share varying degrees of identity/ similarity, including MHV-68 (41%/63%) (38, 53), KSHV (47%/ 67%) (19, 25), and Epstein-Barr virus (EBV) (38%/55%) (23).”
BackgroundKobayashi, R., Kato, A., Oda, S., Koyanagi, N., Oyama, M., Kozuka‐Hata, H., Arii, J., & Kawaguchi, Y. (2015) · Journal of Virology · doi:10.1128/jvi.00547-15 · Cited by 13
“Thr-111 is located in the C-terminal domain of VP26 in HSV-1 and, interestingly, it has also been reported that the VP26 homolog in Epstein-Barr virus is phosphorylated in the C-terminal domain (48).”
BackgroundBerg, L. P., Eriksson, M., Longhi, S., Kockum, I. S., Warnke, C., Thomsson, E., Bäckström, M., Olsson, T. P., Fogdell‐Hahn, A., & Bergström, T. B. (2022) · BMJ Neurology Open · doi:10.1136/bmjno-2022-000271 · Cited by 12
“The online supplemental efigure S1 illustrates the patient material.”
Shen, S., Guo, H., & Deng, H. (2014) · Protein & Cell · doi:10.1007/s13238-013-0005-0 · Cited by 12
“The MHV-68 ORF38 encodes a protein of 75 aa and shares 27% amino acid sequence identity to its homologue in EBV (named BBLF1), which was identified as a component of the virion-associated proteins (Johannsen et al., 2004).”
BackgroundLu, F. Y., Martin, K. A., Soldan, S. S., Kossenkov, A. V., Wickramasinghe, P., Vladimirova, O. V., Leo, A. D., Lin, C., Nefedova, Y., & Lieberman, P. M. (2021) · Journal of Virology · doi:10.1128/jvi.00088-21 · Cited by 13
“BLRF2 was previously shown to be a component of the EBV virion and to interact with the BNRF1 tegument protein (44, 45).”
BackgroundTegument proteins of Epstein-Barr virus: Diverse functions, complex networks, and oncogenesis
Murata, T. (2023) · Tumour Virus Research · doi:10.1016/j.tvr.2023.200260 · Cited by 11
“The protein has been detected in EBV particles [10], but its importance”
BackgroundInfluentialEpstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release
Uddin, M. K., Watanabe, T., Arata, M., Sato, Y., Kimura, H., & Murata, T. (2023) · Journal of Virology · doi:10.1128/jvi.00437-23 · Cited by 12
“Purified EBV particles contain at least 17 virus-encoded tegument proteins, including BBLF1 (37).”
BackgroundDetection and analysis of horizontal gene transfer in herpesvirus
Fu, M., Deng, R., Wang, J., & Wang, X. (2007) · Virus Research · doi:10.1016/j.virusres.2007.08.009 · Cited by 12
Alphaherpesvirus use and misuse of cellular actin and cholesterol
Favoreel, H. W., den Broeke, C. V., Desplanques, A. S., Deruelle, M., Minnebruggen, G. V., Nauwynck, H., Glorieux, S., Opdenbosch, N. V., & Regge, N. D. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.02.007 · Cited by 15
Identification of mumps virus protein and lipid composition by mass spectrometry
Brgles, M., Bonta, M., Šantak, M., Jagušić, M., Forčić, D., Halassy, B., Allmaier, G. M., & Marchetti‐Deschmann, M. (2016) · Virology Journal · doi:10.1186/s12985-016-0463-0 · Cited by 13
“Host cell proteins that were detected are fibronectin, clathrin, actin, histones, heat shock proteins (HSP), annexins, tubulin, ribosomal protein, myosin, and all these proteins were reported to be detected in other viruses also [37–44].”
BackgroundDuck enteritis virus UL21 is a late gene encoding a protein that interacts with pUL16
Yang, L., Wang, M., Zeng, C., Shi, Y., Cheng, A., Liu, M., Zhu, D., Chen, S., Jia, R., Yang, Q., et al. (2020) · BMC Veterinary Research · doi:10.1186/s12917-019-2228-7 · Cited by 12
Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen
McCool, R. S., Acreman, C. M., Powell, A. E., Picucci, S. I., Stieh, D. J., Chou, C., Huynh, J., Caruso, H., Park, S., O’Rear, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-67969-x · Cited by 13
Cable, J. M., Reinoso-Vizcaíno, N. M., White, R. E., & Luftig, M. A. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011950 · Cited by 12
Self-citationWatanabe, T., Sakaida, K., Yoshida, M., Masud, H. M. A. A., Sato, Y., Goshima, F., Kimura, H., & Murata, T. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00125 · Cited by 11
“Mass-spectrometry analysis showed that BRRF2 is detectable as a phosphorylated tegument protein (Johannsen et al., 2004), but its phosphorylation is not mediated by the viral protein kinase BGLF4 (Watanabe et al.”
BackgroundThe antibody response to Epstein–Barr virions is altered in multiple sclerosis
Lindsey, J. W., Khan, U., Ansari, W., Powell, T., Wang, Y. H., & Guirguis, M. S. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.09.007 · Cited by 11
“These antigens are not expected to be present in mature virions (Johannsen et al., 2004), but are likely present in the subcellular fragments which are concentrated with the virus in the pellet after high speed centrifugation.”
BackgroundCai, H., Yao, W., Huang, J., Xiao, J., Chen, W., Hu, L., Mai, R., Liang, M., Chen, D., Jiang, N., et al. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104756 · Cited by 11
Metadata
- Authors
- Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D., & Kieff, E.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kieff, Elliott
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-11-08
- Volume
- 101
- Issue
- 46
- Pages
- 16286-16291
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC528973
- OpenAlex
- W2080385928
- Cited by
- 450
- References
- 35
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 31 · 2023: 31 · 2022: 21 · 2021: 15 · 2020: 23 · 2019: 19 · 2018: 25 · 2017: 18 · 2016: 20 · 2015: 26 · 2014: 19 · 2013: 13 · 2012: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leukemia and Lymphoma Society
- National Institutes of Health (5k08ai049943-02)
- National Cancer Institute (CA47006, CA 85180, R35CA047006, P01CA087661, R01CA047006, R01CA085180, CA87661)
- National Institute of Allergy and Infectious Diseases (1K-08 AI49943-03)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- Epstein-Barr virus, tegument proteins, envelope glycoprotein, lytic replication, actin, cofilin, heat shock proteins, latent infection
- MeSH terms
- Chromatography, Liquid, Clone Cells, Herpesvirus 4, Human, Humans, Lymphocytes, Microscopy, Electron, Phosphorylation, Mass Spectrometry, Viral Envelope Proteins, Viral Proteins, Virus Replication, Open Reading Frames, Capsid Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.